Ernest Mario Overview

  • Investor Type
  • Angel

  • Investments
  • 2

  • Portfolio
  • 1

  • Exits
  • 1

Exits

Ernest Mario General Information

Description

Dr. Ernest Mario serves as a venture partner in Pappas Capital. He served as a Board Member at Peninsula Skincare Labs. He serves as an Advisory Board Executive at Metalmark Capital. He serves as Advisor at Delpor. He also served as Board Member at Kindred Biosciences, Delpor, Balance Therapeutics & Tonix Pharmaceuticals Holding. He also serves as Board Member at Silver Bullet Therapeutics. He also serves as Advisor at Tectonic Ventures. He began his career in 1966 as a pharmaceutical researcher at Strasenburgh Laboratories in Rochester, NY. He later held various management positions within SmithKline and Squibb Corp., overseeing operations, quality control, and manufacturing. He was elected to the Squibb Board in 1984. He joined Glaxo plc in 1986 and subsequently served as Chief Executive and Deputy Chairman. In 1993, he joined Alza Corporation as CEO, where he ultimately consummated with Johnson & Johnson one of the largest mergers in pharmaceutical history. In 2001, he founded Apothogen, a company involved in early-stage pharmaceutical development, which subsequently merged with IntraBiotics. He recently retired from Reliant Pharmaceuticals where he served as CEO and Chairman of the Board of Directors since 2003. He is an adjunct professor of pharmacy at the University of Rhode Island, and also holds honorary doctorates from the University of Rhode Island and Rutgers University. He also served as the Board Member at Boston Scientific. He also serves as Board Member at Fervent Pharmaceuticals. He is the Chairman of the board at Orbus Therapeutics. He previously served as a Chairman of Capnia and Chimerix. He received BS in Pharmacy from Rutgers University, an MS in Physical Sciences from the University of Rhode Island, and a Ph.D. in Physical Sciences from the University of Rhode Island.

Business Details

Primary Investor Type
Angel (individual)
Corporate Office
  • 1177 Avenue of the Americas
  • 40th Floor
  • New York, NY 10036
  • United States
+1 (212) 000-0000

Ernest Mario Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Orbus Therapeutics 19-Aug-2015 Early Stage VC 000.00 Drug Discovery Clinical Trials - Phase 3
Corinthian Ophthalmic 18-Jan-2012 0000 00000 00.000 Other Devices and Supplies Out of Business

Ernest Mario Exits (1)

Company Name Exit Date Exit Type Exit Size
Corinthian Ophthalmic 01-Apr-2013 0000000000: 000000

Ernest Mario Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Ernest Mario Team (1)

Name Title Deals Funds Boards Office
Ernest Mario Ph.D Angel Investor 0 0 0 New York, NY

Ernest Mario FAQs

  • Who is Ernest Mario?

    Ernest Mario is an angel Investor who has made 2 investments.

  • What kind of investor is Ernest Mario?

    Ernest Mario is an angel investor.

  • What does Ernest Mario do?

    As an angel investor, Ernest Mario invests personal money into promising companies, typically in exchange for equity.

  • How many board seats does Ernest Mario hold?

    Ernest Mario holds 2 board seats including Soleno Therapeutics and Fervent Pharmaceuticals.

  • What has Ernest Mario invested in?

    Ernest Mario has made numerous investments in companies like Orbus Therapeutics and Corinthian Ophthalmic within the Drug Discovery and Devices and Supplies industries.

  • What has Ernest Mario invested in recently?

    Ernest Mario's latest investment was on 19-Aug-2015 in Orbus Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »